Brian W. Ellis - 12 Nov 2025 Form 4 Insider Report for DANAHER CORP /DE/ (DHR)

Role
Senior Vice President - GC
Signature
/s/ James F. O'Reilly, attorney-in-fact for Brian W. Ellis
Issuer symbol
DHR
Transactions as of
12 Nov 2025
Net transactions value
-$3,498,007
Form type
4
Filing time
13 Nov 2025, 17:00:27 UTC
Previous filing
03 Nov 2025
Next filing
02 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ellis Brian W Senior Vice President - GC 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON /s/ James F. O'Reilly, attorney-in-fact for Brian W. Ellis 13 Nov 2025 0001662008

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DHR Common Stock Options Exercise $416,516 +7,109 +49% $58.59 21,662 12 Nov 2025 Direct
transaction DHR Common Stock Sale $1,558,386 -7,109 -33% $219.21 14,553 12 Nov 2025 Direct
transaction DHR Common Stock Options Exercise $859,340 +14,667 +101% $58.59 29,220 12 Nov 2025 Direct
transaction DHR Common Stock Sale $3,215,477 -14,667 -50% $219.23 14,553 12 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DHR Employee stock option (right to buy) Options Exercise $0 -7,109 -100% $0.000000 0 12 Nov 2025 Common Stock 7,109 $58.59 Direct F2
transaction DHR Employee stock option (right to buy) Options Exercise $0 -14,667 -100% $0.000000 0 12 Nov 2025 Common Stock 14,667 $58.59 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.110 to $219.410, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 One fifth of the options granted became exercisable on each of the first five anniversaries of the grant date, which was February 24, 2016.
F3 Date shown is grant date. One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date.